August 21, 2014 7:09 PM ET


Company Overview of Valentis Inc.

Company Overview

As of July 13, 2007, Valentis Inc. was acquired by Urigen N.A., Inc., in a reverse merger transaction. Valentis, Inc. does not have significant operations. Previously, the company was engaged in the development of products for peripheral artery disease. Valentis, Inc. was founded in 1992 and is headquartered in Burlingame, California.

533 Airport Boulevard

Suite 400

Burlingame, CA 94010

United States

Founded in 1992





Key Executives for Valentis Inc.

Valentis Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Cryopharm Corporation United States
Metabolic Solutions Development Company, LLC United States
American Type Culture Collection Inc United States
Evotope Biosciences, Inc. United States
Pamlico Biopharma, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Valentis Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at